Patents Assigned to Shire Development Inc.
  • Publication number: 20100035850
    Abstract: The present invention provides methods of treating inflammatory bowel disease comprising administering to a subject in which remission has not been achieved after a first treatment of about 4-8 weeks of 5-ASA (mesalamine or 5-ASA), a further daily dose greater than about 4 g of 5-ASA in controlled release form to achieve a favorable response to treatment.
    Type: Application
    Filed: September 27, 2007
    Publication date: February 11, 2010
    Applicant: Shire Development Inc.
    Inventors: Robyn Gail Karlstadt Meyeroff, Ronald joseph Diebold, David Montague Pierce, Patrick T. Martin